Type 2 reaction associated sensorineural hearing loss in a drug resistant lepromatous leprosy patient: A case report

Abstract

Rationale: Leprosy, a chronic granulomatous disease often present clinically as erythema nodosum leprosum, a type 2 reaction. The involvement of cochlear part of audiovestibular system is a rarity. Patient concerns: A 26-year-old male patient with lepromatous leprosy developed bilateral sensorineural hearing loss (SNHL) during type 2 reactional episode. Diagnosis: Recurrent erythema nodosum leprosum in rifampicin-resistant lepromatous leprosy. Interventions: Corticosteroids and second-line multidrug therapy. Outcomes: The patient improved significantly and was further referred for management of psychosocial impact due to sensorineural hearing loss. Lessons: The hearing impairment is a rare complication of type 2 reaction. Any patient with suspected cranial nerve involvement should essentially be screened by tuning fork tests for early detection of hearing impairment and offer timely intervention as required. All high bacteriological index cases should be investigated for antimicrobial resistance in high endemic areas.

Keywords

Leprosy reactions / Erythema nodosum leprosum / Sensorineural hearing loss / Drug resistant leprosy

References

[1] Nery JA, Bernardes Filho F, Quintanilha J, Machado AM, Oliveira Sde S, Sales AM. Understanding the type 1 reactional state for early diagnosis and treatment: A way to avoid disability in leprosy. An Bras Dermatol 2013; 88(5):787-792.

[2] Brandsma JW, Van Brakel WH. WHO disability grading: Operational definitions. Lepr Rev 2003; 74(4):366-373.

[3] Van Veen NH, Meima A, Richardus JH. The relationship between detection delay and impairment in leprosy control: A comparison of patient cohorts from Bangladesh and Ethiopia. Lepr Rev 2006; 77(4):356-365.

[4] Aubry A, Sammarco Rosa P, Chauffour A, Fletcher ML, Cambau E, Avanzi C. Drug resistance in leprosy: An update following 70 years of chemotherapy. Infect Dis Now 2022; 52(5):243-251.

[5] Chokkakula S, Chen Z, Wang L, Jiang H, Chen Y, Shi Y, et al. Molecular surveillance of antimicrobial resistance and transmission pattern ofMycobacterium leprae in Chinese leprosy patients. Emerg Microb Infect 2019; 8(1):1479-1489.

[6] Lavania M, Jadhav RS, Chaitanya VS, Turankar R, Selvasekhar A, Das L, et al. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending. The Leprosy Mission (TLM) Hospitals in India. Lepr Rev 2014; 85(3):177-185.

[7] Lavania M, Nigam A, Turankar RP, Singh I, Gupta P, Kumar S, et al. Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India. Clin Microbiol Infect 2015; 21(12):e85-e86.

[8] Costa PdSS, Fraga LR, Kowalski TW, Daxbacher ELR, Schuler Faccini L, Vianna FSL. Erythema nodosum leprosum: Update and challenges on the treatment of a neglected condition. Acta Trop 2018; 183:134-141.

[9] Gopinath DV, Thappa DM, Jaishankar TJ. A clinical study of the involvement of cranial nerves in leprosy. Indian J Lepr 2004; 76(1):1-9.

[10] Rawlani S, Patil CY, Bhowte R, Degwekar S, Rawlani S, Chandak R, et al. Evaluation of hearing impairment in leprosy patients taking multidrug therapy. Indian J Lepr 2013; 85(4):171-176.

[11] Awasthi SK, Singh G, Dutta RK, Pahuja OP. Audiovestibular involvement in leprosy. Indian J Lepr 1990; 62(4):429-434.

[12] Reed HM. The psychosocial effects of hearing loss on adults; 2018. [Online]. Available from:https://ideaexchange.uakron.edu/cgi/viewcontent.cgi?article=1625&context=honors_research_projects. [Accessed on 6 January 2023].

[13] Grzybowski A, Nita M, Virmond M. Ocular leprosy. Clin Dermatol 2015; 33(1):79-89.

[14] World Health Organization. Anti-microbial resistance surveillance in leprosy: Report of the virtual meeting; 2021. [Online]. Available from:https://apps.who.int/iris/bitstream/handle/10665/343106/sea-glp-7-eng.pdf?sequence=1. [Accessed on 9 January 2023].